Purified Chick Embryo Cell Culture Rabies Vaccine: interchangeability with Human Diploid Cell Culture Rabies Vaccine and comparison of one versus two-dose post-exposure booster regimen for previously immunized persons

被引:35
|
作者
Briggs, DJ [1 ]
Dreesen, DW
Nicolay, U
Chin, JE
Davis, R
Gordon, C
Banzhoff, A
机构
[1] Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA
[2] Univ Georgia, Coll Vet Med, Athens, GA USA
[3] Aventis Behring, Marburg, Germany
[4] ChironBehring GmbH, Marburg, Germany
关键词
rabies; PCECV; HDCV;
D O I
10.1016/S0264-410X(00)00342-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The equivalence and interchangeability of Purified Chick Embryo Cell Culture Rabies Vaccine (PCECV) to Human Diploid Cell Culture Rabies Vaccine (HDCV) and the immunogenicity of a reduced post-exposure regimen with PCECV was investigated. Statistical analyses revealed no difference (P less than or equal to 0.05) between the geometric mean titers (GMT) on day 49 of subjects that received PCECV or HDCV. In Year 2, subjects were boosted with one or two dose(s) of PCECV. No significant difference (P less than or equal to 0.05) was detected between the GMT of the two groups on days 7 and 365 post-booster. Subjects that received HDCV initially developed an adequate anamnestic response to PCECV. On day 21 post-booster, the GMT of subjects that received two boosters was higher (151.6 IU/ml) than those that received one booster (120.9 IU/ml). However, this difference may not be clinically significant. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1055 / 1060
页数:6
相关论文
共 49 条
  • [41] PRE-EXPOSURE RABIES IMMUNIZATION WITH HUMAN-DIPLOID CELL VACCINE - DECREASED ANTIBODY-RESPONSES IN PERSONS IMMUNIZED IN DEVELOPING-COUNTRIES
    BERNARD, KW
    FISHBEIN, DB
    MILLER, KD
    PARKER, RA
    WATERMAN, S
    SUMNER, JW
    REID, FL
    JOHNSON, BK
    ROLLINS, AJ
    OSTER, CN
    SCHONBERGER, LB
    BAER, GM
    WINKLER, WG
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1985, 34 (03): : 633 - 647
  • [42] Immunogenicity and effectiveness of post-exposure rabies prophylaxis with a new chromatographically purified Vero-cell rabies vaccine (CPRV): a two-stage randomised clinical trial in the Philippines
    Quiambao, BP
    Lang, J
    Vital, S
    Montalban, CG
    Le Mener, V
    Wood, SC
    Miranda, E
    ACTA TROPICA, 2000, 75 (01) : 39 - 52
  • [43] Safety, immunogenicity of lyophilized purified vero cell cultured rabies vaccine administered in Zagreb and Essen regimen in post-exposure subjects: A post-marketing, parallel control clinical trial
    Zhang, Lei
    Huang, Shichun
    Cai, Li
    Zhu, Zhenggang
    Chen, Jian
    Lu, Sha
    Zhu, Zerong
    Zhang, Man
    Fang, Yuan
    Hu, Quan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (08) : 2547 - 2553
  • [44] Safety and immunogenicity of three dose levels of an investigational, highly purified Vero cell rabies vaccine: A randomized, controlled, observer-blinded, Phase II study with a simulated post-exposure regimen in healthy adults
    Pichon, Sylvie
    Guinet-Morlot, Francoise
    Saleh, Jamshid
    Essink, Brandon
    Pineda-Pena, Andrea-Clemencia
    Moureau, Annick
    Petit, Celine
    Minutello, Ada-Maria
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (03)
  • [45] One-week intramuscular or intradermal pre-exposure prophylaxis with human diploid cell vaccine or Vero cell rabies vaccine, followed by simulated post-exposure prophylaxis at one year: A phase III, open-label, randomized, controlled trial to assess immunogenicity and safety
    Quiambao, Beatriz P.
    Lim, Jonathan G.
    Castells, Valerie Bosch
    Augard, Christele
    Petit, Celine
    Bravo, Catherine
    Delore, Valentine
    Houillon, Guy
    VACCINE, 2022, 40 (36) : 5347 - 5355
  • [46] A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab® when administered according to a post-exposure regimen in healthy children and adults in China
    Li, Rongcheng
    Huang, Lirong
    Li, Jia
    Mo, Zhaojun
    He, Bin
    Wang, Yunpeng
    Wu, Xiaohong
    Minutello, Maria
    Guinet-Morlot, Francoise
    Pichon, Sylvie
    VACCINE, 2013, 31 (50) : 5940 - 5947
  • [47] HUMAN-DIPLOID CELL RABIES VACCINE PURIFIED BY ZONAL CENTRIFUGATION - A CONTROLLED-STUDY OF ANTIBODY-RESPONSE AND SIDE-EFFECTS FOLLOWING PRIMARY AND BOOSTER PRE-EXPOSURE IMMUNIZATIONS
    FISHBEIN, DB
    DREESEN, DW
    HOLMES, DF
    PACER, RE
    LEY, AB
    YAGER, PA
    SUMNER, JW
    REIDSANDEN, FL
    SANDERLIN, DW
    TONG, TC
    KEMP, DT
    VACCINE, 1989, 7 (05) : 437 - 442
  • [48] A comparison of the tolerability of two dilution volumes (0.5 mL and 1.0 mL) of a purified chick embryo cell rabies vaccine administered intramuscularly to healthy adult volunteers: A randomized, intraindividual, assessor-blind study
    Kulkarni, R
    Thatte, U
    Shinde, V
    Dharadhar, S
    Poopova, O
    Vakil, H
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2004, 65 (01): : 47 - 56
  • [49] Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: A randomized open-label study
    Li, RongCheng
    Li, YanPing
    Wen, ShuQing
    Wen, HuiChun
    Nong, Yi
    Mo, Zhaojun
    Xie, Fang
    Pellegrini, Michele
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (02) : 435 - 442